BREAKTHROUGH

Calico just used AlphaFold to engineer a novel enzyme against aging

Signals Inbox·July 19, 2026·Longevity

Calico and Revel Pharma reportedly used AlphaFold and directed evolution to engineer a new enzyme against molecular damage linked to aging. The important part is not that AI predicted another protein shape. It is that Alphabet’s longevity lab may now have a tool designed to remove damage the human body struggles to clear on its own.

The Signal, Explained in 3 Minutes

Q1What is the official source?

The research is attributed to Calico and Revel Pharma. Calico publishes its scientific work through its official publications page. The viral post summarizes the paper, but the paper itself should be treated as the source for the exact enzyme, test conditions, and performance numbers.

Q2What actually happened?

The team reportedly used AlphaFold to understand a useful protein structure, then used directed evolution to improve it. Directed evolution means making many enzyme variants, testing them, keeping the best ones, and repeating the process. The result was a new enzyme designed to attack molecular damage associated with aging.

Q3Why is an enzyme important here?

Some age-related damage builds up inside long-lived tissue faster than the body can remove it. Collagen in skin, arteries, joints, and other tissues can remain for years, giving unwanted chemical cross-links time to accumulate. An enzyme could act like a tiny repair tool that finds and cuts a specific form of damage.

Q4What makes this different from most anti-aging drugs?

Many longevity ideas try to slow new damage, reduce inflammation, or change cell behavior. This approach is more direct. It aims to remove damage that already exists. That is a much harder job, but it could also produce a clearer effect if the enzyme reaches the right tissue and works without harming healthy proteins.

Q5Why use both AlphaFold and directed evolution?

AlphaFold can help researchers understand what a protein may look like and which changes might matter. But a prediction is not enough. Directed evolution tests real enzyme variants in the lab. One narrows the search, while the other proves which versions actually perform the chemistry.

Q6Does this mean Calico can reverse aging?

No. An engineered enzyme working in a laboratory is very different from a medicine that safely repairs human tissue. Calico still has to show that it works in animals, reaches the right organs, avoids immune reactions, clears meaningful amounts of damage, and creates a measurable health benefit.

Q7So why does it matter now?

Because AI protein tools are moving from describing biology to designing new biological functions. Calico was created more than a decade ago and has often looked distant from a real anti-aging product. A purpose-built repair enzyme would make that bet more concrete, although the gap between a strong paper and a human therapy is still enormous.

← Back to the signals